The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
A 3-Level Prognostic Classification in Septic Shock Based on Cortisol Levels and Cortisol Response to Corticotropin
Abstract
CONTEXT: The hypothalamic-pituitary-adrenal axis is a major determinant of the host response to stress. The relationship between its activation and patient outcome is not known. OBJECTIVE: To evaluate the prognostic value of cortisol levels and a short corticotropin stimulation test in patients with septic shock. DESIGN AND SETTING: Prospective inception cohort study conducted between October 1991 and September 1995 in 2 teaching hospital adult intensive care units in France. PARTICIPANTS: A total of 189 consecutive patients who met clinical criteria for septic shock. INTERVENTION: A short corticotropin stimulation test was performed in all patients by intravenously injecting 0.25 mg of tetracosactrin; blood samples were taken immediately before the test (T0) and 30 (T30) and 60 (T60) minutes afterward. MAIN OUTCOME MEASURES: Twenty-eight-day mortality as a function of variables collected at the onset of septic shock, including cortisol levels before the corticotropin test and the cortisol response to corticotropin (delta max, defined as the difference between T0 and the highest value between T30 and T60). RESULTS: The 28-day mortality was 58% (95% confidence interval [CI], 51%-65%) and median time to death was 17 days (95% CI, 14-27 days). In multivariate analysis, independent predictors of death (P < or = .001 for all) were McCabe score greater than 0, organ system failure score greater than 2, arterial lactate level greater than 2.8 mmol/L, ratio of PaO2 to fraction of inspired oxygen no more than 160 mm Hg, cortisol level at T0 greater than 34 microg/dL and delta max no more than 9 microg/dL. Three groups of patient prognoses were identified: good (cortisol level at T0 < or = 34 microg/dL and delta max > 9 microg/dL; 28-day mortality rate, 26%), intermediate (cortisol level at T0 34 microg/dL and delta max < or = 9 microg/dL or cortisol level at T0 > 34 microg/dL and delta max > 9 microg/dL; 28-day mortality rate, 67%), and poor (cortisol level at T0 > 34 microg/dL and delta max < or = 9 microg/dL; 28-day mortality rate, 82%). CONCLUSION: Our data suggest that a short corticotropin test has a good prognostic value and could be helpful in identifying patients with septic shock at high risk for death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Short-term hormone dysfunction could also be explained by acute phase inflammation and stress49505152.”
From Endocrine dysfunction following traumatic brain injury: a 5-year follow-up nationwide-based study (2016) · cites this paper as [51]
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Prognosis in Acute Organ-System Failure
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Annals of Surgery · doi:10.1097/00000658-198512000-00004 · Cited by 1,220
Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults
Brun‐Buisson, C. (1995) · JAMA · doi:10.1001/jama.274.12.968 · Cited by 1,079
Reversal of late septic shock with supraphysiologic doses of hydrocortisone
Bollaert, P., Charpentier, C., Lévy, B., Debouverie, M., Audibert, G., & Larcan, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00010 · Cited by 863
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
Bone, R. C., Fisher, C. J., Clemmer, T. P., Gj, S., METZ, C. A., & BALK, R. A. (1989) · PubMed · Cited by 689
Anti-inflammatory therapies to treat sepsis and septic shock
Zéni, F., Freeman, B. D., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Neuroendocrine-Immune Interactions
Epstein, F. H., & Reichlin, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310213291708 · Cited by 566
Calandra, T., Baumgartner, J. D., Grau, G. E., Wu, M.-M., Lambert, P., Schellekens, J. F. P., Verhoef, J., Glauser, M. P., & Swiss-Dutch J5 Immunoglobulin Study Group (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.5.982 · Cited by 546
Corticosteroid Therapy in Severe Illness
Lamberts, S. W. J., Bruining, H. A., & de Jong, F. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710303371807 · Cited by 477
Impact of encephalopathy on mortality in the sepsis syndrome
Sprung, C. L., Peduzzi, P. N., Shatney, C. H., Schein, R. M. H., Wilson, M. F., Sheagren, J. N., & Hinshaw, L. B. (1990) · Critical Care Medicine · doi:10.1097/00003246-199008000-00001 · Cited by 426
Cortisol response to corticotropin and survival in septic shock
Rothwell, P. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)91641-7 · Cited by 407
Annane, D., Bellissant, Sebille, V., Lesieur, O., Mathieu, Raphael, & Gajdos (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00833.x · Cited by 295
Self-citationSoni, A., Pepper, G. M., Wyrwinski, P. M., Ramirez, N. E., Simón, R., Pina, T., Gruenspan, H., & Vaca, C. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80373-8 · Cited by 273
Variations in Adrenocortical Responsiveness During Severe Bacterial Infections
Sibbald, W. J., SHORT, A., Cohen, M. P., & Wilson, R. F. (1977) · Annals of Surgery · doi:10.1097/00000658-197707000-00005 · Cited by 249
Hypothermia in the sepsis syndrome and clinical outcome
Clemmer, T. P., Fisher, C. J., Bone, R. C., Slotman, G. J., METZ, C. A., & Thomas, F. O. (1992) · Critical Care Medicine · doi:10.1097/00003246-199210000-00006 · Cited by 248
Melby, J. C., & Spink, W. W. (1958) · Journal of Clinical Investigation · doi:10.1172/jci103772 · Cited by 237
Prediction of outcome in intensive care patients using endocrine parameters
Rothwell, P. M., & Lawler, P. G. (1995) · Critical Care Medicine · doi:10.1097/00003246-199501000-00015 · Cited by 219
Spectrum of Serum Cortisol Response to ACTH in ICU Patients
Jurney, T. H., Cockrell, J. L., Jurney, T. H., Lindberg, J. S., Lamiell, J. M., & Wade, C. E. (1987) · CHEST Journal · doi:10.1378/chest.92.2.292 · Cited by 206
Knaus, W. A. (1993) · JAMA · doi:10.1001/jama.270.10.1233 · Cited by 206
Plasma cortisol levels in patients with septic shock
Schein, R. M. H., Sprung, C. L., Marcial, E. H., Napolitano, L. M., & Chernow, B. (1990) · Critical Care Medicine · doi:10.1097/00003246-199003000-00002 · Cited by 193
McCabe, W. R. (1973) · Disease-a-Month · doi:10.1016/s0011-5029(73)80016-1 · Cited by 190
Adrenocortical function during septic shock
Bouachour, G., Tirot, P., Gouëllo, J. P., Esposito, M., Vincent, J. F., & Alquier, P. (1995) · Intensive Care Medicine · doi:10.1007/bf02425155 · Cited by 162
Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock
Moran, L., Chapman, M. J., O'Fathartaigh, M. S., Peisach, A. R., Pannall, P. R., & Leppard, P. (1994) · Intensive Care Medicine · doi:10.1007/bf01711901 · Cited by 156
SERUM CORTISOL LEVELS IN SEVERELY STRESSED PATIENTS
Finlay, W. I., & Mckee, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92531-4 · Cited by 146
CORTISOL REPLACEMENT IN SEVERELY STRESSED PATIENTS
Mckee, J., & Finlay, W. I. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91489-7 · Cited by 138
Variable adrenocortical function in acute medical illness
Drucker, D. J., & Shandling, M. R. (1985) · Critical Care Medicine · doi:10.1097/00003246-198506000-00007 · Cited by 122
Pugeat, M., Emptoz-Bonneton, A., Perrot, D., Rocle, B., Lejeune, H., Grenot, C., Déchaud, H., Brébant, C., Motin, J. P., & Cuilleron, C. Y. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.8.1675 · Cited by 121
Wade, C. E., Lindberg, J. S., COCKRELL, J. L., Lamiell, J. M., Hunt, M. M., Ducey, J. P., & Jurney, T. H. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-2-223 · Cited by 115
A Critical Evaluation of New Agents for the Treatment of Sepsis
Bone, R. C. (1991) · JAMA · doi:10.1001/jama.1991.03470120088038 · Cited by 109
Corticosteroids in septic shock
Matot, I., & Sprung, C. L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00002 · Cited by 76
Adrenal functions in patients with sepsis *
Aygen, B., Inan, M., Doğanay, M., & Keleştimur, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211749 · Cited by 67
Contribution of cortisol deficiency to septic shock
Briegel, J., Forst, H., Hellinger, H., & Haller, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)90575-a · Cited by 54
Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids
Schneider, A. J. (1991) · Intensive Care Medicine · doi:10.1007/bf01720688 · Cited by 53
DISTRIBUTION OF INJECTED CORTISOL-4-C14IN NORMAL AND SHOCKED RATS
Firschein, H. E., DeVenuto, F., WALTER, M. F., Pearce, E. M., & Westphal, U. (1957) · Endocrinology · doi:10.1210/endo-60-3-347 · Cited by 30
Haemodynamic improvement in refractory septic shock with cortisol replacement therapy
Briegel, J. (1992) · Intensive Care Medicine · doi:10.1007/bf01706486 · Cited by 29
Annane, D., Raphaël, J., & Gajdos, P. (1996) · Critical Care Medicine · doi:10.1097/00003246-199605000-00035 · Cited by 13
Self-citation
Cited by
Sorted by citations
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,309
“g ACTH stimulation test (responders) identifies survivors of septic shock (42).”
BackgroundAnnane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,075
Self-citationSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,038
“One study demonstrated that an incremental increase of 9 g/dL after 250- g ACTH stimulation test (responders) identifies survivors of septic shock (42).”
BackgroundHydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R. P., Singer, M., Freivogel, K., Weiss, Y., Benbenishty, J. S., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,162
Self-citation
Metadata
- Authors
- Annane, D.
- Affiliations
- Hôpital Raymond-Poincaré (FR)
- Corresponding author
- Annane, Djillali
- ORCID
- Annane, Djillali
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2000-02-23
- Volume
- 283
- Issue
- 8
- Pages
- 1038
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2156618518
- Cited by
- 1,000
- References
- 40
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 15 · 2023: 19 · 2022: 15 · 2021: 13 · 2020: 19 · 2019: 22 · 2018: 27 · 2017: 27 · 2016: 27 · 2015: 26 · 2014: 44 · 2013: 35 · 2012: 38
- FWCI
- 38.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- septic shock, cortisol, ACTH stimulation test, tetracosactrin, hypothalamic-pituitary-adrenal axis, prognostic stratification, 28-day mortality, stress response, organ failure, lactate, PaO2/FiO2 ratio, intensive care unit patients, corticosteroid therapy, sepsis
- MeSH terms
- Adult, Cosyntropin, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Prognosis, Prospective Studies, Severity of Illness Index, Shock, Septic, Biomarkers, Multivariate Analysis, Proportional Hazards Models, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review